|
Antineoplastic Agents – Framework Agreement For The Supply Of Medicines Pn3 - Cost Volume 2026 – 2027 + Other Medicines. Zoledronic Acid 4 Mg,Aflibercept 100 Mg,Bleomycinum Sulfas 15000Ui,Cabazitaxelum 60 Mg,Carboplatinum 450 Mg,Cemiplimabum 350 Mg,Docetaxelum 80 Mg,Doxorubicinum Liposomal Nepegilat 50 Mg,Doxorubicinum Lipos. Pegilat 20 Mg,Durvalumabum 500 Mg,Epirubicin 100 Mg,Epirubicine 50 Mg,Eribulinum 0.88 Mg,Etoposidum 200 Mg,Filgrastimum 30 Mi/0.5 Ml,Filgrastimum 48 Mi/0.5 Ml,Fluorouracilum 1000 Mg,Gemcitabine 1000 Mg,Gemcitabine 2000 Mg,Irinotecanum 300 Mg,Oxaliplatinum 100 Mg,Paclitaxelum 300 Mg,Panitumumabum 100 Mg,Panitumumabum 400 Mg,Pegfilgrastimum 6Mg/0.6 Ml,Pegfilgrastimum Injector Preumplut 6Mg/0.6 Ml,Sacituzumab Govitecan 200 Mg,Topotecamum 4 Mg,Trastuzumabum Deruxtecanum 100 Mg,Trastuzumabum Emtansinum 100 Mg,Trastuzumabum Emtansinum 160 Mg,Vinorelbinum 50 Mg,Irinotecanum Pegylat Liposomal 43 Mg/Ml - 10 Ml,Durvalumabum 120 Mg,Tebentafusp 100Mcg/5Ml,Tetanic Vaccin Adsorbit 0.5 Ml Susp.Inj
|